Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2009 Oct 30;9(5):179–191. doi: 10.4110/in.2009.9.5.179

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2009 The Korean Association of Immunologists

This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Levels of IFN-γ and IL-4 cytokines in splenic supernatants of PBS/peptide-treated mice groups (P1-P3) in prophylactic (A) and therapeutic regimen (B) quantitated by sandwich ELISA and their respective IFN-γ/IL-4 ratios shown below the graph. Each regimen had 5 groups of mice: Non-challenged control, PBS-treated Afu-challenged (prophylactic) or ABPA (therapeutic), P1-treated, P2-treated and P3-treated mice. Data represents the mean±SD of triplicate determinations with five mice per group, ^*p<0.05 versus PBS-treated Afu challenged (prophylactic) or ABPA mice (therapeutic).